ClinicalTrials.Veeva

Menu

22G FNA Needle vs. 22G ProCore Needle

AdventHealth logo

AdventHealth

Status

Completed

Conditions

Pancreatic Neoplasm

Treatments

Procedure: 22G ProCore biopsy needle
Procedure: 22G standard FNA needle

Study type

Interventional

Funder types

Other

Identifiers

NCT01394159
F110506010

Details and patient eligibility

About

The aim of this research study is to identify the best needle for performing biopsy during EUS procedures. There are two types of needles for performing biopsy: A FNA needle that provides a small sample of tissue for analysis and a 22G ProCore needle that provides larger amount of tissue. It is not clear at this point which of the two needles is superior for performing biopsy. This study will attempt to identify the better needle by assessing the performance of both needles in a randomized fashion.

Full description

In this randomized trial, the 22G standard fine needle aspiration needle was compared with the newly developed 22G ProCore needle for sampling pancreatic mass lesions during endoscopic ultrasound. Patients were randomized into the two needle groups and then various outcomes were compared between the two needle types, including the number of passes needed to establish a diagnosis, the ability to procure enough tissue sample to be able to make a diagnosis, the rates of needle failure and complication rates.

Enrollment

56 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-All patients with solid pancreatic mass lesions

Exclusion criteria

  • Coaguloapthy,
  • minors,
  • prgenant patients

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

56 participants in 2 patient groups

22G ProCore biopsy needle
Active Comparator group
Description:
Using the 22G ProCore needle for sampling pancreatic mass lesions, the tissue obtained will be compared to the standard FNA needle.
Treatment:
Procedure: 22G ProCore biopsy needle
22G standard FNA needle
Active Comparator group
Description:
Using the 22G standard fine needle aspiration needle (FNA) for sampling pancreatic mass lesions, the tissue obtained will be compared to the 22 G ProCore needle.
Treatment:
Procedure: 22G standard FNA needle

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems